
March 9 (Reuters) - HUTCHMED (China) Ltd 0013.HK:
IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINA
WITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALS
ІPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERІK IN US